This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

An Evaluation of the Pharmacokinetics and Safety of LIPO-102 in Healthy Volunteers

This study has been completed.
Information provided by (Responsible Party):
Neothetics, Inc Identifier:
First received: June 10, 2009
Last updated: March 19, 2015
Last verified: March 2015
An Evaluation of the PK and Safety of LIPO-102 in Healthy Volunteers.

Condition Intervention Phase
Subcutaneous Adipose Tissue Reduction Drug: LIPO-102 Phase 1

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment

Further study details as provided by Neothetics, Inc:

Primary Outcome Measures:
  • Safety: Laboratory tests, medical exams [ Time Frame: 4 weeks ]

Secondary Outcome Measures:
  • Pharmacokinetics [ Time Frame: 24 hours ]

Enrollment: 30
Study Start Date: February 2009
Study Completion Date: June 2009
Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: LIPO-102 Drug: LIPO-102


Ages Eligible for Study:   18 Years to 55 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Male and non pregnant female
  • 18-55 years old
  • Sufficient abdominal fat for injections
  • Signed informed consent

Exclusion Criteria:

  • Known hypersensitivity to study drugs
  • Treatment with an investigational agent within 30 days before first dose
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00918606

United States, Maryland
Baltimore, Maryland, United States
Sponsors and Collaborators
Neothetics, Inc
  More Information

Responsible Party: Neothetics, Inc Identifier: NCT00918606     History of Changes
Other Study ID Numbers: LIPO-102-CL-01
Study First Received: June 10, 2009
Last Updated: March 19, 2015 processed this record on September 19, 2017